Skip to content

EndogenousTestosterone Response to a Testosterone Boosting Supplement

EndogenousTestosterone Response to a Testosterone Boosting Supplement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02600650
Enrollment
60
Registered
2015-11-09
Start date
2015-11-30
Completion date
2016-06-30
Last updated
2015-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Testosterone

Brief summary

The purpose of this study is to determine whether a proprietary 'testosterone-boosting' supplement, when used as recommended by the manufacturer, results in an increase in testosterone levels as measured by a salivary free testosterone assay.

Detailed description

The experimental intervention in this study is the daily administration of a testosterone boosting supplement or sham supplement for 4 weeks. The supplement will be administered daily in capsule form. The control group will be given a sham capsule containing the carrier components of the supplement. Participants will be asked not to modify their current lifestyle. Salivary testosterone levels will be assessed prior to the intervention to collect a baseline measurement for each subject, and following the intervention to evaluate any changes in hormone levels.

Interventions

DIETARY_SUPPLEMENTTestosterone boosting supplement

Proprietary formulation of Testosterone boosting supplement administered daily

DIETARY_SUPPLEMENTPlacebo Comparator

Daily administration of Placebo Comparator

Sponsors

Iovate Health Sciences International Inc
CollaboratorINDUSTRY
Canadian Memorial Chiropractic College
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult male aged 20 to 40 years. * Fluent in English.

Exclusion criteria

* Currently receiving hormonal therapy or testosterone boosting supplement. * Has received hormonal therapy or testosterone boosting supplement within 3 months prior to study. * Has experienced adverse event following previous exposure to testosterone boosting supplements.

Design outcomes

Primary

MeasureTime frameDescription
Change in concentration of salivary free testosterone from baseline measured by ELISA4 weeksChange in concentration of salivary free testosterone from baseline to 4 weeks will be measured by ELISA

Countries

Canada

Contacts

Primary Contactmark fillery, B.A.
mfillery@cmcc.ca+1 416 482-2340
Backup Contactbrian budgell, Ph.D.
bbudgell@cmcc.ca+1 416 482-2340

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026